Valuation: LifeMD, Inc.

Market Cap 201M 175M 162M 149M 281M 19.33B 287M 1.93B 761M 9.47B 754M 737M 32.59B P/E 2026 *
-15.2x
P/E 2027 * 55.9x
Enterprise Value 201M 175M 162M 149M 281M 19.33B 287M 1.93B 761M 9.47B 754M 737M 32.59B EV / Sales 2026 *
0.9x
EV / Sales 2027 * 0.77x
Free-Float
85.9%
Yield 2026 *
-
Yield 2027 * -
1 day-7.78%
1 week-10.56%
Current month+0.48%
1 month-12.63%
3 months+1.47%
6 months+10.08%
Current year+21.70%
1 week 4.09
Extreme 4.09
4.88
1 month 3.9
Extreme 3.9
5.1
Current year 2.56
Extreme 2.56
5.38
1 year 2.56
Extreme 2.56
12.72
3 years 2.56
Extreme 2.56
15.84
5 years 1.14
Extreme 1.14
15.84
10 years 0.42
Extreme 0.421
33.02
Manager TitleAgeSince
Chief Executive Officer 39 01/08/2025
Director of Finance/CFO 57 16/03/2026
Chief Tech/Sci/R&D Officer - 01/06/2026
Director TitleAgeSince
Chairman 65 -
Director/Board Member 75 04/09/2014
Chairman 43 11/06/2019
Date Insider Type Main position Quantity % Market Cap.
11/5/26 Free

Chief Financial Officer

337,500 0.7035%
30/3/26 Free

Responsable ventes & marketing

200,000 0.4155%
9/12/25 Sell

Executive/Senior Manager

15,000 0.0312%
Change 5-day change 1-year change 3-year change Capi.($)
-7.78%-10.56%-60.66%+6.68% 201M
-1.01%+2.77%-30.79%-6.68% 31.74B
-3.46%-5.05%-42.95%+184.23% 13.65B
-1.43%-2.55%-24.06%+67.70% 5.5B
-4.20%-6.89% - - 2.15B
-2.40%+2.11%+70.65%-32.02% 2.09B
-0.73%-5.34% - - 1.74B
-4.23%-2.47%-39.86% - 1.07B
-3.80%-5.00%+45.69%+106.33% 901M
-6.74%-2.64%-41.34%-55.97% 759M
Average -3.58%-3.56%-15.42%+38.61% 5.98B
Weighted average by Cap. -1.96%-0.43%-28.50%+48.56%

Financials

2026 *2027 *
Net sales 222M 194M 179M 165M 311M 21.38B 318M 2.14B 842M 10.47B 834M 816M 36.05B 261M 228M 210M 194M 366M 25.13B 374M 2.51B 989M 12.31B 980M 958M 42.36B
Net income -13.11M -11.46M -10.58M -9.75M -18.37M -1.26B -18.78M -126M -49.72M -619M -49.25M -48.17M -2.13B 3.57M 3.12M 2.88M 2.66M 5.01M 344M 5.12M 34.45M 13.55M 169M 13.42M 13.13M 580M
Net Debt - -
Logo LifeMD, Inc.
LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
Employees
350
Date Price Change Volume
17/07/26 US$4.150 -7.78% 621,789
16/07/26 US$4.500 -0.66% 558,166
15/07/26 US$4.530 +0.44% 354,584
14/07/26 US$4.510 -5.25% 550,376
13/07/26 US$4.760 +2.59% 527,596
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
4.150USD
Average target price
9.875USD
Spread / Average Target
+137.95%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFMD Stock